Quoting Agenus’s post on LinkedIn:
“Mark your calendars! We have been selected for a poster presentation at the American Society of Clinical Oncology (ASCO)’s ASCO2024 Annual Meeting.
Join us on June 1st as we present a sub-analysis of the MSS colorectal cancer cohort from our Phase 1b study of botensilimab and balstilimab. See the details here.”
Source: Agenus/LinkedIn